[
  {
    "id": "ng180",
    "title": "NICE NG180: Perioperative Care in Adults",
    "content": "\n            Perioperative Care in Adults - NICE Guideline NG180\n            \n            Preoperative Assessment:\n            - Assess cardiovascular risk\n            - Optimize management of long-term conditions\n            - Provide information about the procedure and recovery\n            - Screen for malnutrition and optimize nutritional status\n            - Assess venous thromboembolism (VTE) risk\n            \n            Preoperative Fasting:\n            - Clear fluids: up to 2 hours before anesthesia\n            - Light meal: up to 6 hours before anesthesia\n            - Chewing gum and sweets should be avoided during fasting\n            \n            Perioperative Fluids:\n            - Use isotonic crystalloids (e.g., Ringer's lactate, Hartmann's)\n            - Avoid 0.9% saline for large volume replacement\n            - Restrict fluids during surgery if appropriate\n            - Goal-directed fluid therapy for major surgery\n            \n            Temperature Management:\n            - Maintain normothermia (36.0°C or above)\n            - Use warming devices for procedures >30 minutes\n            - Monitor temperature throughout perioperative period\n            \n            VTE Prophylaxis:\n            - Mechanical prophylaxis: intermittent pneumatic compression\n            - Pharmacological: LMWH unless contraindicated\n            - Continue prophylaxis postoperatively based on risk\n            \n            Pain Management:\n            - Multimodal analgesia approach\n            - Regular paracetamol and NSAIDs if not contraindicated\n            - Opioids for breakthrough pain\n            - Regional techniques when appropriate\n            \n            Postoperative Nausea and Vomiting (PONV):\n            - Risk assessment using scoring system\n            - Prophylaxis for high-risk patients\n            - Multiple antiemetic agents for very high risk\n            \n            Enhanced Recovery:\n            - Early mobilization\n            - Early oral intake when safe\n            - Avoid nasogastric tubes routinely\n            - Remove urinary catheters early\n            ",
    "source": "NICE",
    "url": "https://www.nice.org.uk/guidance/ng180",
    "length": 1500
  },
  {
    "id": "ng24",
    "title": "NICE NG24: Blood Transfusion",
    "content": "\n            Blood Transfusion - NICE Guideline NG24\n            \n            Red Blood Cell Transfusion Thresholds:\n            \n            Acute Blood Loss:\n            - Hemoglobin <70 g/L: consider transfusion\n            - Cardiovascular disease: consider at Hb <80 g/L\n            - Acute coronary syndrome: maintain Hb 80-100 g/L\n            \n            Chronic Anemia:\n            - Threshold depends on symptoms and comorbidities\n            - Generally consider transfusion below 70 g/L\n            - Higher threshold (80 g/L) if cardiovascular disease\n            \n            Transfusion Strategy:\n            - Single unit transfusion for non-bleeding patients\n            - Reassess after each unit\n            - Target Hb increment of 10-20 g/L per unit\n            \n            Massive Transfusion Protocol:\n            - Activate early in major hemorrhage\n            - RBC:FFP:Platelets ratio of 1:1:1\n            - Give calcium after 4 units (ionized calcium falls)\n            - Monitor for hypothermia, acidosis, coagulopathy\n            - Consider tranexamic acid within 3 hours\n            \n            Platelet Transfusion:\n            - Active bleeding: maintain >50 × 10⁹/L\n            - Major hemorrhage: maintain >75 × 10⁹/L\n            - Prophylactic: <10 × 10⁹/L (hematology patients)\n            \n            Fresh Frozen Plasma (FFP):\n            - PT ratio or APTT ratio >1.5 with bleeding\n            - Massive transfusion: 1:1 ratio with RBCs\n            - Dose: 12-15 mL/kg\n            \n            Complications:\n            - TRALI (Transfusion-Related Acute Lung Injury)\n            - TACO (Transfusion-Associated Circulatory Overload)\n            - Hemolytic reactions\n            - Infections\n            \n            Documentation:\n            - Indication for transfusion\n            - Discussion with patient\n            - Adverse events\n            - Patient response to transfusion\n            ",
    "source": "NICE",
    "url": "https://www.nice.org.uk/guidance/ng24",
    "length": 1400
  },
  {
    "id": "ng51",
    "title": "NICE NG51: Sepsis - Recognition, Diagnosis and Early Management",
    "content": "\n            Sepsis: Recognition, Diagnosis and Early Management - NICE NG51\n            \n            Recognition:\n            High-risk criteria (any of):\n            - Objective evidence of new altered mental state\n            - Systolic BP <90 mmHg or drop >40 from baseline\n            - Heart rate >130 per minute\n            - Respiratory rate ≥25 per minute\n            - Needs oxygen to maintain SpO2 ≥92%\n            - Non-blanching rash, mottled/ashen/cyanotic\n            - Not passed urine in 18 hours (<0.5 mL/kg/hour if catheterized)\n            - Lactate ≥2 mmol/L\n            \n            Moderate to High-Risk Criteria:\n            - Relatives concerned about mental status\n            - Acute deterioration in functional ability\n            - Immunosuppressed\n            - Trauma/surgery/invasive procedure in last 6 weeks\n            - Respiratory rate 21-24\n            - Systolic BP 91-100 mmHg\n            - Heart rate 91-130 or new arrhythmia\n            - Temperature <36°C\n            - Clinical signs of wound infection\n            \n            Initial Management (within 1 hour):\n            1. Blood cultures before antibiotics\n            2. Measure lactate\n            3. Monitor urine output\n            4. Start broad-spectrum antibiotics\n            5. IV fluid resuscitation if needed\n            6. Measure oxygen saturation and give oxygen\n            \n            Antibiotic Therapy:\n            - Give within 1 hour of diagnosis\n            - Broad-spectrum initially\n            - Review and adjust based on culture results\n            - Typical regimen: piperacillin-tazobactam or meropenem\n            \n            Fluid Resuscitation:\n            - 500 mL crystalloid bolus over <15 minutes if:\n              * Systolic BP <90 mmHg\n              * Lactate ≥2 mmol/L\n            - Reassess after each bolus\n            - Consider senior review if >30 mL/kg given\n            \n            Monitoring:\n            - Continuous monitoring if high risk\n            - Lactate clearance (repeat in 1-2 hours)\n            - Urine output\n            - Blood pressure\n            - Conscious level\n            \n            Escalation:\n            - Critical care involvement if:\n              * Lactate ≥4 mmol/L\n              * Systolic BP <90 despite fluids\n              * Altered mental state\n              * Respiratory rate >25\n            \n            Source Control:\n            - Identify and treat source\n            - Drain collections\n            - Remove infected devices\n            - Debride infected tissue\n            ",
    "source": "NICE",
    "url": "https://www.nice.org.uk/guidance/ng51",
    "length": 1800
  },
  {
    "id": "cg174",
    "title": "NICE CG174: Intravenous Fluid Therapy in Adults in Hospital",
    "content": "\n            Intravenous Fluid Therapy in Adults - NICE CG174\n            \n            Assessment (5 Rs):\n            1. Resuscitation - immediate fluid needs\n            2. Routine maintenance - daily fluid and electrolyte needs\n            3. Replacement - ongoing losses\n            4. Redistribution - fluid shifts\n            5. Reassessment - continuous monitoring\n            \n            Resuscitation Fluids:\n            - Use crystalloids (Hartmann's or Ringer's lactate preferred)\n            - Initial bolus: 500 mL over <15 minutes\n            - Reassess after each bolus using ABCDE\n            - Avoid 0.9% saline for resuscitation (hyperchloremic acidosis risk)\n            \n            Maintenance Fluids:\n            - 25-30 mL/kg/day water (about 2-2.5 L for 70 kg adult)\n            - 1 mmol/kg/day sodium, potassium, chloride\n            - 50-100 g/day glucose to limit starvation ketosis\n            \n            Typical Maintenance Regimen:\n            - 1 L Hartmann's or Ringer's lactate with 20 mmol KCl over 8-12 hours\n            - 1 L 5% glucose with 20 mmol KCl over 8-12 hours\n            - Alternate or adjust based on electrolytes\n            \n            Fluid Overload:\n            Signs:\n            - Pulmonary edema\n            - Peripheral edema\n            - Raised JVP\n            - Weight gain\n            \n            Management:\n            - Restrict fluid intake\n            - Consider diuretics\n            - Stop maintenance fluids\n            \n            Monitoring:\n            - Fluid balance charts (input/output)\n            - Weight (daily if possible)\n            - Clinical assessment (edema, JVP, lung sounds)\n            - Electrolytes daily while on IV fluids\n            - Urine output (aim >0.5 mL/kg/hour)\n            \n            Special Considerations:\n            \n            Elderly:\n            - Lower fluid requirements\n            - Higher risk of fluid overload\n            - Monitor carefully\n            \n            Heart Failure:\n            - Restrict fluids\n            - Smaller boluses (250 mL)\n            - Senior review early\n            \n            Renal Impairment:\n            - Adjust potassium content\n            - Monitor U&Es closely\n            - Consider fluid restriction\n            \n            Electrolyte Replacement:\n            \n            Hypokalemia:\n            - <3.5 mmol/L: add 40 mmol KCl per liter\n            - <3.0 mmol/L: consider additional oral supplements\n            - <2.5 mmol/L: senior review, cardiac monitoring\n            \n            Hyponatremia:\n            - Assess volume status first\n            - Hypovolemic: resuscitate with 0.9% saline\n            - Euvolemic: fluid restrict\n            - Never correct >10 mmol/L in 24 hours\n            ",
    "source": "NICE",
    "url": "https://www.nice.org.uk/guidance/cg174",
    "length": 1900
  },
  {
    "id": "acls-cardiac-arrest",
    "title": "ACLS Adult Cardiac Arrest Algorithm",
    "content": "\n            Adult Cardiac Arrest Algorithm (ACLS):\n            \n            1. Start CPR - Give oxygen - Attach monitor/defibrillator\n            \n            2. Check rhythm - Shockable rhythm?\n            \n            If VF/pVT (Shockable):\n            - Shock\n            - Resume CPR immediately for 2 minutes\n            - IV/IO access\n            - Epinephrine every 3-5 minutes\n            - Amiodarone for refractory VF/pVT\n            \n            If Asystole/PEA (Non-Shockable):\n            - Resume CPR immediately for 2 minutes\n            - IV/IO access\n            - Epinephrine every 3-5 minutes\n            - Treat reversible causes\n            \n            During CPR:\n            - Minimize interruptions\n            - Rotate compressor every 2 minutes\n            - Capnography if available (target ETCO2 >10 mmHg)\n            - Continuous compressions once advanced airway in place\n            \n            Reversible Causes (H's and T's):\n            - Hypovolemia\n            - Hypoxia\n            - Hydrogen ion (acidosis)\n            - Hypo-/hyperkalemia\n            - Hypothermia\n            - Tension pneumothorax\n            - Tamponade (cardiac)\n            - Toxins\n            - Thrombosis (pulmonary)\n            - Thrombosis (coronary)\n            \n            Drug Dosing:\n            - Epinephrine 1 mg IV/IO every 3-5 minutes\n            - Amiodarone 300 mg IV/IO first dose, then 150 mg\n            ",
    "source": "AHA",
    "url": "https://cpr.heart.org/en/resuscitation-science/cpr-and-ecc-guidelines",
    "length": 1200
  },
  {
    "id": "acls-bradycardia",
    "title": "ACLS Bradycardia Algorithm",
    "content": "\n            Adult Bradycardia Algorithm (ACLS):\n            \n            Definition: Heart rate <60 bpm with symptoms\n            \n            1. Assess appropriateness for clinical condition\n            2. Identify and treat underlying cause\n            3. Monitor and observe\n            \n            Signs of poor perfusion:\n            - Hypotension\n            - Altered mental status\n            - Signs of shock\n            - Acute heart failure\n            - Chest pain\n            \n            If symptomatic bradycardia:\n            \n            First line: Atropine\n            - Dose: 1 mg IV bolus\n            - Repeat every 3-5 minutes\n            - Maximum total dose: 3 mg\n            \n            If atropine ineffective:\n            \n            Consider:\n            - Transcutaneous pacing\n            - Dopamine infusion 5-20 mcg/kg/min\n            - Epinephrine infusion 2-10 mcg/min\n            \n            Prepare for transvenous pacing if:\n            - High-degree AV block\n            - Complete heart block\n            - Refractory to medications\n            ",
    "source": "AHA",
    "url": "https://cpr.heart.org/en/resuscitation-science/cpr-and-ecc-guidelines",
    "length": 800
  },
  {
    "id": "acls-tachycardia",
    "title": "ACLS Tachycardia Algorithm",
    "content": "\n            Adult Tachycardia Algorithm (ACLS):\n            \n            Definition: Heart rate >100 bpm\n            \n            1. Assess stability\n            2. Identify rhythm\n            3. Treat based on rhythm and stability\n            \n            Unstable (immediate cardioversion):\n            - Hypotension\n            - Altered mental status\n            - Signs of shock\n            - Chest pain\n            \n            Stable Narrow-Complex (<0.12 sec):\n            \n            Regular:\n            - Vagal maneuvers\n            - Adenosine 6 mg rapid IV push, then 12 mg if needed\n            - If refractory: β-blocker or calcium channel blocker\n            \n            Irregular:\n            - Likely atrial fibrillation\n            - Rate control: β-blocker, diltiazem, or digoxin\n            - Consider anticoagulation\n            \n            Stable Wide-Complex (≥0.12 sec):\n            \n            Regular:\n            - If known SVT with aberrancy: treat as narrow complex\n            - Otherwise treat as VT:\n              - Amiodarone 150 mg over 10 min\n              - Procainamide\n              - Sotalol\n            \n            Irregular:\n            - Likely afib with aberrancy or pre-excitation\n            - Avoid AV nodal blocking agents\n            - Expert consultation\n            \n            Synchronized Cardioversion:\n            - Narrow regular: 50-100 J\n            - Narrow irregular: 120-200 J biphasic\n            - Wide regular: 100 J\n            - Wide irregular: defibrillation dose\n            ",
    "source": "AHA",
    "url": "https://cpr.heart.org/en/resuscitation-science/cpr-and-ecc-guidelines",
    "length": 1100
  }
]